Keloids are locally exuberant dermal scars characterized by excessive fibroblast proliferation and matrix accumulation. Although treatment strategies include surgical removal and intralesional steroid injections, an effective regimen is yet to be established due to a high rate of recurrence. The regressing center and growing margin of the keloid have different collagen architecture and also differ in the rate of proliferation. To investigate whether proliferation is responsive to collagen topography, keloid, scar, and dermal fibroblasts were cultured on nanopatterned scaffolds varying in collagen fibril diameter and alignment-small and large diameter, aligned and random fibrils, and compared to cells grown on flat collagen-coated substrates, respectively. Cell morphology, proliferation, and expression of six genes related to proliferation (cyclin D1), phenotype (α-smooth muscle actin), and matrix synthesis (collagens I and III, and matrix metalloproteinase-1 and -2) were measured to evaluate cell response. Fibril alignment was shown to reduce proliferation and matrix synthesis in all three types of fibroblasts. Further, keloid cells were found to be most responsive to nanotopography.
Get full access to this article
View all access options for this article.
References
1.
ShihB., GarsideE., McGroutherD.A., and BayatA.Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen, 18, 39, 2010.
2.
AtiyehB.S., CostagliolaM., and HayekS.N.Keloid or hypertrophic scar: the controversy: review of the literature. Ann Plast Surg, 54, 676, 2005.
3.
OngC.T., KhooY.T., MukhopadhyayA., DoD.V., LimI.J., AalamiO., and PhanT.T.mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Exp Dermatol, 16, 394, 2007.
4.
AtiyehB.Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg, 31, 468, 2007.
5.
SeifertO., BayatA., GeffersR., DienusK., BuerJ., LöfgrenS., and MatussekA.Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen, 16, 254, 2008.
6.
AppletonI., BrownN.J., and WilloughbyD.A.Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol, 149, 1441, 1996.
7.
VerhaegenP.D.H.M., Van ZuijlenP.P.M., PenningsN.M., Van MarleJ., NiessenF.B., Van Der HorstC.M.A.M., and MiddelkoopE.Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis. Wound Repair Regen, 17, 649, 2009.
8.
EhrlichH.P., DesmouliereA., DiegelmannR.F., CohenI.K., ComptonC.C., GamerW.L., KapanciY., and GabbianiG.Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol, 145, 105, 1994.
9.
KnappT.R., DanielsJ.R., and KaplanE.N.Pathologic scar formation: morphologic and biochemical correlates. Am J Pathol, 86, 47, 1977.
10.
LeeJ.Y., YangC.C., ChaoS.C., and WongT.W.Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol, 26, 379, 2004.
11.
Da CostaV., WeiR., LimR., SunC.H., BrownJ.J., and WongB.J.Nondestructive imaging of live human keloid and facial tissue using multiphoton microscopy. Arch Facial Plast Surg, 10, 38, 2008.
12.
ChungH.J., SteplewskiA., ChungK.Y., UittoJ., and FertalaA.Collagen fibril formation: a new target to limit fibrosis. J Biol Chem, 283, 25879, 2008.
13.
Al-AttarA., MessS., ThomassenJ.M., KauffmanC.L., and DavisonS.P.Keloid pathogenesis and treatment. Plast Reconstr Surg, 117, 286, 2006.
14.
Har-ShaiY., AmarM., and SaboE.Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg, 111, 1841, 2003.
15.
ParkinsonL.G., ReaS.M., StevensonA.W., WoodF.M., and FearM.W.The effect of nano-scale topography on keratinocyte phenotype and wound healing following burn injury. Tissue Eng Part A, 18, 703, 2012.
16.
AyalaP., LopezJ.I., and DesaiT.Microtopographical cues in 3D attenuate fibrotic phenotype and extracellular matrix deposition: implications for tissue regeneration. Tissue Eng Part A, 16, 2519, 2010.
17.
MuthusubramaniamL., PengL., ZaitsevaT., PaukshtoM., MartinG.R., and DesaiT.A.Collagen fibril diameter and alignment promote the quiescent keratocyte phenotype. J Biomed Mater Res A, 100A, 613, 2011.
18.
SchmultsC.D., PhelpsR., and GoldbergD.J.Nonablative facial remodeling: erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd:YAG laser. Arch Dermatol, 140, 1373, 2004.
19.
SmithJ.C., BooneB.E., OpalenikS.R., WilliamsS.M., and RussellS.B.Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol, 128, 1298, 2007.
IyerV.R., EisenM.B., RossD.T., SchulerG., MooreT., LeeJ.C.F., TrentJ.M., StaudtL.M., HudsonJ., BoguskiM.S., LashkariD., ShalonD., BotsteinD., and BrownP.O.The transcriptional program in the response of human fibroblasts to serum. Science, 283, 83, 1999.
22.
FujiwaraM., MuragakiY., and OoshimaA.Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol, 153, 295, 2005.
23.
ChenC.S., MrksichM., HuangS., WhitesidesG.M., and IngberD.E.Micropatterned surfaces for control of cell shape, position, and function. Biotechnol Prog, 14, 356, 1998.
24.
SinghviR., KumarA., LopezG.P., StephanopoulosG.N., WangD.I., WhitesidesG.M., and IngberD.E.Engineering cell shape and function. Science, 264, 696, 1994.
25.
TohP.P., LiJ.J., YipG.W., LoS.L., GuoC.H., PhanT.T, and BayB.H.Modulation of metallothionein isoforms is associated with collagen deposition in proliferating keloid fibroblasts in vitro. Exp Dermatol, 19, 987, 2010.
26.
CalderonM., LawrenceW.T., and BanesA.J.Increased proliferation in keloid fibroblasts wounded in vitro. J Surg Res, 61, 343, 1996.
27.
BettingerD.A., YagerD.R., DiegelmannR.F., and CohenI.K.The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg, 98, 827, 1996.
28.
StaceyD.W.Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol, 15, 158, 2003.
29.
ChipevC.C., SimmanR., HatchG., KatzA.E., SiegelD.M., and SimonM.Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ, 7, 166, 2000.
30.
TheoretC.L., OlutoyeO.O., ParnellL.K.S., and HicksJ.Equine exuberant granulation tissue and human keloids: a comparative histopathologic study. Vet Surg, 42, 783, 2013.
31.
SantucciM., BorgognoniL., RealiU.M., and GabbianiG.Keloids and hypertrophic scars of caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch, 438, 457, 2001.
32.
LeeY.S., and VijayasingamS.Mast cells and myofibroblasts in keloid: a light microscopic, immunohistochemical and ultrastructural study. Ann Acad Med Singapore, 24, 902, 1995.
33.
SyedF., AhmadiE., IqbalS.A., SinghS., McGroutherD.A., and BayatA.Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol, 64, 83, 2011.
34.
FriedmanD.W., BoydC.D., MackenzieJ.W., NortonP., OlsonR.M., DeakS.B.Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res, 55, 21, 1993.
35.
ImaizumiR., AkasakaY., InomataN., OkadaE., ItoK., IshikawaY., and MaruyamaY.Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression. Histopathology, 54, 722, 2009.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
